Amgen Inc (NASDAQ: AMGN ) is one of the most prominent biopharmaceutical companies in the world. The company specializes in research and development to manufacture medicines to treat various diseases, which include inflammation, rare diseases, cardiovascular diseases, etc. Amgen operates in nearlyEver since I was eleven years old, I have been an ardent follower of the Stock Market and avid of learning new investing concepts. By providing fundamental analysis on dividend and growth equities across diverse se ...

公司概况 - BioCryst Pharmaceuticals是一家在晶体学和基于结构的药物设计领域处于领先地位的公司 专注于开发治疗癌症、心血管疾病、自身免疫性疾病和病毒感染的新型疗法 [1] - 公司股票代码为BCRX 目前获得Zacks Rank 1(强力买入)评级 [1] 财务表现 - 过去60天内 市场对BioCryst Pharmaceuticals下一年度盈利的共识预期大幅上调83.3% [1] - 过去三个月公司股价累计上涨39% 显著跑赢同期标普500指数2.2%的涨幅 [2] 市场动能 - 公司动量得分为B级 显示出较强的股价上涨动能 [2]